C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
195/1.22, 167/10
C12N 15/58 (2006.01) A61K 38/49 (2006.01) A61P 7/02 (2006.01) A61P 9/10 (2006.01) C12N 1/21 (2006.01) C12N 5/10 (2006.01) C12N 9/72 (2006.01) C12N 15/63 (2006.01) C12Q 1/37 (2006.01) A61K 38/00 (2006.01)
Patent
CA 1341484
Tissue plasminogen activator (t-PA) zymogens and variants are prepared, including a fibrinolytically active variant of t-PA that has an amino acid alteration at a site within the protease domain of t-PA as compared with the corresponding wild-type t-PA, which alteration renders the variant zymogenic in the presence of plasmin-degraded fibrinogen, and/or fibrin (or plasma clot) specific, as compared to the corresponding wild-type t-PA. DNA sequences can be prepared that encode the zymogens and variants, as well as expression vectors incorporating the DNA sequences, and host cells transformed with the expression vectors. The zymogens and variants may be used in a pharmaceutical preparation to treat a vascular disease or condition or to prevent fibrin deposition or adhesion formation or reformation in mammals.
610241
Anderson Stephen
Bennett William F.
Botstein David
Higgins Deborah L.
Paoni Nicholas F.
Dennison Associates
Genentech Inc.
LandOfFree
Tissue plasminogen activator having zymogenic or fibrin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tissue plasminogen activator having zymogenic or fibrin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tissue plasminogen activator having zymogenic or fibrin... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1301844